FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activationTaewoo Yang, Sung‐Gyoo Park|Journal of Experimental & Clinical Cancer Research|2022Cited by 23